Introduction
- How is ASCVD risk assessed
- What are the benefits and disadvantages of the various available risk assessment tools?
- Is metabolic syndrome a stronger predictor of CV risk compared to CV risk scoring tools?
- How do emerging risk markers further refine risk stratification?